申请人:Beiersdorf Aktiengesellschaft
公开号:US04323570A1
公开(公告)日:1982-04-06
The present invention is directed to certain aminopyrimidines of the general formula ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 are hydrogen, halogen, alkoxy, alkylthio, or alkyl having 1 to 4 carbon atoms, or cycloalkyl having 3 to 5 carbon atoms and R.sup.4 is hydrogen or an aliphatic or aromatic acyl group, as well as physiologically compatible acid addition salts thereof. Compounds of the present invention are useful as blood pressure lowering agents and in the treatment of glaucoma.
本发明涉及一些氨基嘧啶,其一般式为##STR1##其中R.sup.1、R.sup.2和R.sup.3为氢、卤素、烷氧基、烷基硫基或具有1至4个碳原子的烷基,或具有3至5个碳原子的环烷基,R.sup.4为氢或脂肪族或芳香族酰基,以及其生理兼容性酸盐。本发明的化合物可用作降血压剂和青光眼治疗。